BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.42% |
| 2 | Financials | 8.28% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.29% |
| 5 | Communication Services | 4.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTLF
2676
DELISTED
Heartland Financial USA, Inc.
HTLF
| $261K | ﹤0.01% |
5,558
-9,760
| -64% | -$486K |
|
2677
Par Pacific Holdings
PARR
$4.08B
| $261K | ﹤0.01% |
15,509
-5,504
| -26% | -$82.7K |
|
|
CHUY
2678
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $259K | ﹤0.01% |
6,949
-3,175
| -31% | -$135K |
|
|
RVNC
2679
DELISTED
Revance Therapeutics, Inc.
RVNC
| $259K | ﹤0.01% |
8,725
-10,254
| -54% | -$296K |
|
|
CCRN
2680
DELISTED
Cross Country Healthcare
CCRN
| $257K | ﹤0.01% |
15,582
-1,582
| -9% | -$24.2K |
|
|
FISV
2681
CALL
Fiserv Inc
FISV
$29B
| $257K | ﹤0.01% |
24
| – | – |
|
2682
Sanofi
SNY
$105B
| $256K | ﹤0.01% |
4,858
+3,070
| +172% | +$160K |
|
|
ZUO
2683
DELISTED
Zuora, Inc.
ZUO
| $255K | ﹤0.01% |
14,806
-16,512
| -53% | -$264K |
|
2684
PDF Solutions
PDFS
$2.13B
| $250K | ﹤0.01% |
13,761
+7,858
| +133% | +$141K |
|
|
HEP
2685
DELISTED
Holly Energy Partners, L.P.
HEP
| $249K | ﹤0.01% |
10,992
+39
| +0.4% | +$826 |
|
2686
WisdomTree
WT
$3.45B
| $249K | ﹤0.01% |
40,109
-29,088
| -42% | -$192K |
|
2687
Brown-Forman Class A
BF.A
$13.2B
| $248K | ﹤0.01% |
3,523
-421
| -11% | -$30K |
|
2688
CBIZ
CBZ
$2.96B
| $248K | ﹤0.01% |
7,579
-12,608
| -62% | -$421K |
|
2689
Vuzix
VUZI
$227M
| $247K | ﹤0.01% |
+13,452
| New | +$272K |
|
2690
Yext
YEXT
$593M
| $245K | ﹤0.01% |
17,138
-11,540
| -40% | -$161K |
|
2691
Brookfield Renewable
BEP
$10.5B
| $244K | ﹤0.01% |
6,331
-5,119
| -45% | -$203K |
|
2692
Marcus Corp
MCS
$915M
| $244K | ﹤0.01% |
11,497
-242
| -2% | -$5.03K |
|
|
KRTX
2693
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $243K | ﹤0.01% |
2,134
+144
| +7% | +$16.8K |
|
2694
BCE
BCE
$21.9B
| $242K | ﹤0.01% |
4,900
| – | – |
|
2695
First Interstate BancSystem
FIBK
$3.72B
| $239K | ﹤0.01% |
5,722
-12,259
| -68% | -$566K |
|
2696
Akebia Therapeutics
AKBA
$243M
| $239K | ﹤0.01% |
63,068
-11,500
| -15% | -$38.7K |
|
2697
Workhorse Group
WKHS
$33.2M
| $238K | ﹤0.01% |
5
-10
| -67% | -$370K |
|
|
SWAV
2698
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $238K | ﹤0.01% |
1,253
-2,465
| -66% | -$403K |
|
2699
Axsome Therapeutics
AXSM
$11.3B
| $238K | ﹤0.01% |
3,524
-2,762
| -44% | -$166K |
|
|
RDFN
2700
DELISTED
Redfin
RDFN
| $238K | ﹤0.01% |
3,747
-9,989
| -73% | -$611K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.